Navigation Links
SYBRGreen II RNA gel stain from Sigma-Aldrich

ProductsSYBRGreen II RNA gel stain from Sigma-Aldrich
Company Sigma-Aldrich
Item SYBRGreen II RNA gel stain
Price 
Description Packaging: package with 500 l
Patent/trademark/license (electronic): (r) Registered trademark of Molecular Probes
Info Sigma-AldrichSigma-Aldrich
Sigma-Aldrich Corp.
St. Louis, MO, USA
Customer Service: 800-325-3010
Tech Support: 800-325-5832
Fax Number: 314-771-5757
Web Site: http://www.sigmaaldrich.com/
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. SYBRGreen I nucleic acid gel stain from Sigma-Aldrich
2. ATX Ponceau S red staining solution from Sigma-Aldrich
3. SYBR Green II RNA gel stain*10,000X concentrate in DMSO* from Molecular Probes (Invitrogen)
4. SYBR Green II RNA gel stain*10,000X concentrate in DMSO* from Molecular Probes (Invitrogen)
5. SYBR Green II RNA gel stain*10,000X concentrate in DMSO**special packaging* from Molecular Probes (Invitrogen)
6. Human / Mouse / Rat Blood Vessels (CD31 / Von Willebrand Factor (vWF)) IHC staining Kit from CHEMICON
7. SYBR Green I nucleic acid gel stain*10,000X concentrate in DMSO* from Molecular Probes (Invitrogen)
8. SYBR Green I nucleic acid gel stain*10,000X concentrate in DMSO**special packaging* from Molecular Probes (Invitrogen)
9. SYBR Green I nucleic acid gel stain from Molecular Probes (Invitrogen)
10. SYBR Safe DNA Gel Stain Starter Kit - with 1 L of SYBR Safe DNA gel stain in 0.5X TBE (S33100) and one photographic filter (S37100) from Molecular Probes (Invitrogen)
11. Giemsa stain from Sigma-Aldrich
ready-to-use solution...
Applications: ISH...
... & visualization software. See ... samples. Combine Sequest and ... confidence. Get more detailed ... your MS/MS experiments.14 day ...
... Clone/PAD: ZMD.420. Immunogen: Recombinant ... Specificity: Specific for the ~44 ... Reactivity: Human (positive control: IFN-Gamma-stimmulated ... on sequence homology reactivity with ...
Biology Products:
(Date:1/18/2017)... 18, 2017  In vitro diagnostic (IVD) companies were ... acquisitions (M&A), and Kalorama Information expects that trend to ... been shifting. Generally, uncertainty in reimbursement and healthcare reform ... has changed the acquisitions landscape. Instead of looking to ... buying partners outside of their home country and also ...
(Date:1/12/2017)... 12, 2017  Trovagene, Inc. (NASDAQ: TROV ... today announced that it has signed agreements with seven ... the Middle East for commercialization ... the first wave of international distribution agreements for Trovagene,s ... samples. The initial partners will introduce Trovagene,s ...
(Date:1/11/2017)... Iowa , Jan. 11, 2017 Intoxalock, ... first with the release of its patent-pending calibration device. ... and reliably perform calibrations, securely upload data logs and ... for the customer. "Fighting drunk driving through ... for the public at large, but also for the ...
Breaking Biology News(10 mins):
(Date:1/20/2017)... , January 20, 2017 ... cancer is one of leading causes of death worldwide. ... Although the number of cancer related deaths increased gradually ... Rising in incidence rate of various cancers continues to ... a research report by Global Market Insights, Inc. cancer ...
(Date:1/19/2017)... Future has a half cooked research report on Global Liquid Biopsy ... expected to reach USD 450 Million by the end of the ... ... as a swiftly growing market and expected that the market will ... has been a tremendous growth in the prevalence of cancer disease ...
(Date:1/19/2017)... 19, 2017 Research and Markets ... has announced the addition of the ... Forecast to 2025" report to their offering. ... The report provides a detailed analysis on current and future market trends ... using estimated market values as the base numbers Key ...
(Date:1/19/2017)... GAITHERSBURG, Md. , Jan. 19, 2017 ... Inc., a privately-held immunotherapeutics company targeting infectious diseases, ... for the merger of PharmAthene and Altimmune in ... Venture Fund, HealthCap, Truffle Capital and Redmont Capital. ... diversified immunotherapeutics company with four clinical stage and ...
Breaking Biology Technology: